Agios Pharmaceuticals Statistics
NASDAQ: AGIOHealth CareBiotechnology: Pharmaceutical PreparationsUSD
31.45-0.34 (-1.07%)
Market open · Delayed 15 min · as of Oct 8, 12:12 PM ET
Agios Pharmaceuticals by the numbers
Agios Pharmaceuticals has a market capitalization of $1.88 billion based on 59.70M shares outstanding. With trailing EPS of $-7.03, Agios Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 5.1% below its 50-day average and 1.1% above its 200-day average.
Average daily trading volume is 1.05M shares, or about $33.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
AGIO valuation vs. peer median
| Metric | AGIO | Peer median | Difference |
|---|---|---|---|
| Market cap | $1.88B | $1.87B | +1% |
| Avg. volume | 1.05M | 1.54M | -32% |
Peer median across 8 companies: LKFT, MLYS, ADRX, XERS, SRPT, PRGO, SDGR, PVLA.
Valuation
- Market cap
- $1.88B
- EPS (TTM)
- $-7.03
- Shares outstanding
- 59.70M
Price and trading
- Previous close
- 31.79
- Open
- 31.46
- Day range
- 31.16 – 31.77
- 52-week range
- 22.24 – 46.00
- 52-week change
- -22.22%
- Beta
- —
- Volume
- 152.03K
- Average volume
- 1.05M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Oct 29, 2026
Additional statistics
- Market Cap
- 1.88B
- Forward Pe
- -7.91
- Eps
- -7.03
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 46.00
- Week52 Low
- 22.24
- Avg Volume
- 1.05M
- Shares Outstanding
- 59.70M
- Ma50
- 33.15
- Ma200
- 31.11
- Earnings Date
- Oct 29, 2026
- Pct From52w High
- -31.63%
- Pct From52w Low
- 41.41%